ClinicalTrials.gg
RecruitingNCT07420673Updated Nov 5, 2026

Measurement of Expiratory Gas Temperature in Intubated Patients to Estimate Expiratory Absolute Humidity

An observational study in Mechanical Ventilator Care, sponsored by Laval University. Recruiting at 1 site in Canada. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-05.

Sponsored by Laval University · Observational

How we know

From the registry’s dates

  • Started May 2026; still recruiting 5 months later.
Updated Nov 5, 2026Now RecruitingSite recruiting status changed+3 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
70
Ages
18 Years and older
Sex
All
01

Study summary

Adequate humidification is essential for intubated patients because dry medical gases can cause thick secretions and dangerous endotracheal tube blockages. A clear correlation exists between exhaled and inhaled humidity delivered by heat and moisture exchanger. The objective of this study is to measure the temperature of exhaled gases in intubated patients in order to accurately calculate the absolute humidity during the expiratory phase. These data will allow for a more accurate reproduction of real clinical conditions during bench testing and will improve the assessment of heat and moisture exchanger performance device evaluation.

Read the detailed description

Previous clinical studies suggest that real expiratory humidity in intubated patients is close to 35 mg H₂O/L, with expiratory temperatures around 32-33 °C or slightly lower. However, data are limited, heterogeneous, and often derived from anesthetized patients. Therefore, accurate measurement of expiratory temperature in intensive care patients under normothermia and across varying body temperatures is necessary to define realistic simulation standards and ensure reliable heat and moisture exchanger performance evaluation on a bench. A relationship between expiratory gases temperature and expiratory humidity exist.

02

Conditions studied

  • Mechanical Ventilator Care

Keywords

  • humidification
  • Passive humidification
03

In context

Lead sponsor

Laval University is the lead sponsor of 380 studies on the registry; 67 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Intubated patient using a heater and moist exchanger

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults (≥18 years)
  • Intubated and mechanically ventilated in the intensive care unite
  • Using passive humidification (Heat and Moisture exchanger)

Exclusion criteria

Exclusion Criteria:

  • PEEP set \< 12 cmH₂O
  • Inhaled nitric oxide therapy
  • Tracheostomy
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
70 participants (estimated)
Patient registry
No

Groups and cohorts

  • Normothermic patient

    Normothermic patient under mechanical ventilation with passive humification (heat and moisture exchanger) with body temperature between 36.0 and 38.0 Celsius degrees

    Other: Expiratory gases temperature

  • Hypothermic patient

    Hypothermic patient under mechanical ventilation with passive humification (heat and moisture exchanger) with body temperature \< 36.0 Celsius degrees

    Other: Expiratory gases temperature

  • Hyperthermic patient

    Hyperthermic patient under mechanical ventilation with passive humification (heat and moisture exchanger) with body temperature \> 38.0 Celsius degrees

    Other: Expiratory gases temperature

Interventions

  • OtherExpiratory gases temperature

    Measure expiratory gas temperature immediately before the passive humidifier in intubated ICU patients and evaluate the relationship between body temperature and expiratory temperature.

06

What researchers measure

Primary outcomes

  1. Expiratory gas temperature

    Measure expiratory gas temperature immediately before the passive humidifier

    Time frame: H0, up to 60 minutes after inclusion

  2. Relationship between body temperature and expiratory temperature.

    Evaluate the relationship between body temperature and expiratory temperature

    Time frame: H0, up to 60 minutes after inclusion

Secondary outcomes

  1. Estimate expiratory absolute humidity based on measured temperature

    Time frame: H0, up to 60 minutes after inclusion

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Started May 2026 (actual). Primary completion is estimated for Dec 2027, 19 months after the start.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 5, 2026: start Apr 2026 → May 2026, primary completion Dec 2026 → Dec 2027 and completion Jun 2027 → Jun 2028.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Feb 12, 2026
First posted
Feb 19, 2026
StartActual
May 25, 2026was Apr 2026
Primary completionEst.
Dec 2027was Dec 2026
CompletionEst.
Jun 2028was Jun 2027
Last update
Nov 5, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Nov 5, 2026
Sites
Insitut universitaire de cardiologie et de pneumologie de Quebec - Universite Laval is now Recruiting
Nov 5, 2026
Start date
Apr 2026→May 25, 2026 (actual)
Nov 5, 2026
Primary completion
Dec 2026→Dec 2027
Nov 5, 2026
Study completion
Jun 2027→Jun 2028
Nov 5, 2026
Site contacts
Changed at 1 site. See the sites
Show the site
  • Insitut universitaire de cardiologie et de pneumologie de Quebec - Universite Laval · Québec, CanadaContact added f•••@criucpq.ulaval.ca · •••8711
Nov 5, 2026
Show all 1 update
  1. Nov 5, 2026
    Not yet recruiting→Recruiting
    Insitut universitaire de cardiologie et de pneumologie de Quebec - Universite Laval is now Recruiting
    Start date Apr 2026→May 25, 2026 (now actual)
    Primary completion Dec 2026→Dec 2027
    Study completion Jun 2027→Jun 2028
    Site contacts Changed at 1 site. See the sites
    Show the site
    • Insitut universitaire de cardiologie et de pneumologie de Quebec - Universite Laval · Québec, CanadaContact added f•••@criucpq.ulaval.ca · •••8711
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07420673
Lead sponsor
Laval University
Responsible party
François Lellouche (Principal Investigator, Laval University) — Principal investigator
First posted
Feb 19, 2026
Start date
May 25, 2026
Primary completion
Dec 2027 (estimated)
Completion
Jun 2028 (estimated)
Last update
Nov 5, 2026

Study contacts

Francois Lellouche, MD, PhD
Contact
francois.lellouche@criucpq.ulaval.ca
1 418-656-8711 ext. 3572

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion